News Image

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

Provided By PR Newswire

Last update: May 22, 2025

Real-World Analysis Shows Statistically Significant Reduction in Severe Bleeding and Transfusion Needs in CABG Patients on the Blood Thinner, Ticagrelor, with CytoSorbents Therapy

Read more at prnewswire.com

CYTOSORBENTS CORP

NASDAQ:CTSO (8/29/2025, 8:14:47 PM)

After market: 0.9564 +0.01 (+1.38%)

0.9434

+0.01 (+0.84%)



Find more stocks in the Stock Screener

CTSO Latest News and Analysis

Follow ChartMill for more